{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:13:54Z","timestamp":1790828034515,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science","award":["26253021"],"award-info":[{"award-number":["26253021"]}]},{"name":"Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science","award":["26860232"],"award-info":[{"award-number":["26860232"]}]},{"name":"Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science","award":["16K19074"],"award-info":[{"award-number":["16K19074"]}]},{"name":"the Core Research for Evolutionary Science and Technology program from the Japan Science and Technology Agency","award":["16gm0510010h0005"],"award-info":[{"award-number":["16gm0510010h0005"]}]},{"name":"the Core Research for Evolutionary Sciene and Technology Program from Japan Science and Technology Agency","award":["16m0510010h005"],"award-info":[{"award-number":["16m0510010h005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00428-019-02724-4","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T21:08:26Z","timestamp":1576271306000},"page":"353-365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Thirty years of Epstein-Barr virus-associated gastric carcinoma"],"prefix":"10.1007","volume":"476","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0460-064X","authenticated-orcid":false,"given":"Masashi","family":"Fukayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Kunita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Shinozaki-Ushiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Matsusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Ushiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"key":"2724_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/s0140-6736(64)91524-7","volume":"15","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet 15:702\u2013703. https:\/\/doi.org\/10.1016\/s0140-6736(64)91524-7","journal-title":"Lancet"},{"key":"2724_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2015","unstructured":"Young LS, Yap LF, Murray PG (2015) Epstein-Barr virus: more than 50 years old and still providing surprises. Nature Rev Cancer 16:789\u2013802. https:\/\/doi.org\/10.1038\/nrc.2016.92","journal-title":"Nature Rev Cancer"},{"key":"2724_CR3","first-page":"377","volume":"3","author":"AP Burke","year":"1990","unstructured":"Burke AP, Yen TS, Shekitka KM, Sobin LH (1990) Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 3:377\u2013380","journal-title":"Mod Pathol"},{"key":"2724_CR4","doi-asserted-by":"publisher","first-page":"9006","DOI":"10.1073\/pnas.83.23.9006","volume":"83","author":"JG Howe","year":"1986","unstructured":"Howe JG, Steitz JA (1986) Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci U S A 83:9006\u20139010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2724_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ijc.2910460509","volume":"46","author":"TC Wu","year":"1990","unstructured":"Wu TC, Mann RB, Charache P, Hayward SD, Staal S, Lambe BC, Ambinder RF (1990) Detection of EBV gene expression in reed-Sternberg cells of Hodgkin's disease. Int J Cancer 46:801\u2013804","journal-title":"Int J Cancer"},{"key":"2724_CR6","first-page":"469","volume":"139","author":"D Shibata","year":"1991","unstructured":"Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM (1991) Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 139:469\u2013474","journal-title":"Am J Pathol"},{"key":"2724_CR7","first-page":"1250","volume":"143","author":"M Tokunaga","year":"1993","unstructured":"Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E (1993) Epstein-Barr virus in gastric carcinoma. Am J Pathol 143:1250\u20131254","journal-title":"Am J Pathol"},{"key":"2724_CR8","first-page":"73","volume":"71","author":"M Fukayama","year":"1994","unstructured":"Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K (1994) Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Investig 71:73\u201381","journal-title":"Lab Investig"},{"key":"2724_CR9","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1053\/j.gastro.2009.05.001","volume":"137","author":"G Murphy","year":"2009","unstructured":"Murphy G, Pfeiffer R, Camargo MC, Rabkin CS (2009) Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterol 137:824\u2013833. https:\/\/doi.org\/10.1053\/j.gastro.2009.05.001","journal-title":"Gastroenterol"},{"key":"2724_CR10","doi-asserted-by":"publisher","first-page":"20160270","DOI":"10.1098\/rstb.2016.0270","volume":"372","author":"S Tsao","year":"2017","unstructured":"Tsao S, Tsang CM, Lo KW (2017) Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc London B Biol Sci 372:20160270. https:\/\/doi.org\/10.1098\/rstb.2016.0270","journal-title":"Philos Trans R Soc London B Biol Sci"},{"key":"2724_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/978-981-10-7230-7_20","volume":"1045","author":"M Fukayama","year":"2018","unstructured":"Fukayama M, Kunita A, Kaneda A (2018) Gastritis-infection-cancer sequence of Epstein-Barr virus-associated gastric carcinoma. Adv Exp Med Biol 1045:437\u2013457. https:\/\/doi.org\/10.1007\/978-981-10-7230-7_20","journal-title":"Adv Exp Med Biol"},{"key":"2724_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-319-24738-0_3","volume":"879","author":"HH Niller Niller","year":"2016","unstructured":"Niller Niller HH, Banati F, Salamon D (2016) Minarovits J (2016) Epigenetic alterations in Epstein-Barr virus-associated diseases. Adv Exp Med Biol 879:39\u201369. https:\/\/doi.org\/10.1007\/978-3-319-24738-0_3","journal-title":"Adv Exp Med Biol"},{"key":"2724_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"The Cancer Genome Atlas Research Network","year":"2014","unstructured":"The Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202\u2013209. https:\/\/doi.org\/10.1038\/nature13480","journal-title":"Nature"},{"key":"2724_CR14","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim ST, Cristescu R, Bass AJ, Kim KM, Odegaard JI, Kim K, Liu XQ, Sher X, Jung H, Lee M, Lee S, Park SH, Park JO, Park YS, Lim HY, Lee H, Choi M, Talasaz A, Kang PS, Cheng J, Loboda A, Lee J, Kang WK (2018) Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med 24:1449\u20131458. https:\/\/doi.org\/10.1038\/s41591-018-0101-z","journal-title":"Nat Med"},{"key":"2724_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-019-0743-4","volume":"12","author":"P Gao","year":"2019","unstructured":"Gao P, Lazare C, Cao C, Meng Y, Wu P, Zhi W, Lin S, Wei J, Huang X, Xi L, Chen G, Hu J, Ma D, Wu P (2019) Immune checkpoint inhibitors in the treatment of virus-associated cancers. J Hematol Oncol 12:58. https:\/\/doi.org\/10.1186\/s13045-019-0743-4","journal-title":"J Hematol Oncol"},{"key":"2724_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.prp.2011.07.004","volume":"207","author":"M Fukayama","year":"2011","unstructured":"Fukayama M, Ushiku T (2011) Epstein-Barr virus-associated gastric carcinoma. Pathol Res Pract 207:529\u2013537. https:\/\/doi.org\/10.1016\/j.prp.2011.07.004","journal-title":"Pathol Res Pract"},{"key":"2724_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.gastro.2010.04.002","volume":"139","author":"HJ Song","year":"2010","unstructured":"Song HJ, Srivastava A, Lee J, Kim YS, Kim KM, Kang WK, Kim M, Kim S, Park CK, Kim S (2010) Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology 139:84\u201392.e2. https:\/\/doi.org\/10.1053\/j.gastro.2010.04.002","journal-title":"Gastroenterology"},{"key":"2724_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/gutjnl-2013-304531","volume":"63","author":"MC Camargo","year":"2014","unstructured":"Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, Yu J, Sung JJ, Herrera-Goepfert R, Meneses-Gonzalez F, Kijima Y, Natsugoe S, Liao LM, Lissowska J, Kim S, Hu N, Gonzalez CA, Yatabe Y, Koriyama C, Hewitt SM, Akiba S, Gulley ML, Taylor PR, Rabkin CS (2014) Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut 63:236\u2013243. https:\/\/doi.org\/10.1136\/gutjnl-2013-304531","journal-title":"Gut"},{"key":"2724_CR19","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10120-015-0565-1","volume":"19","author":"JH Park","year":"2016","unstructured":"Park JH, Kim EK, Kim YH, Kim JH, Bae YS, Lee YC, Cheong JH, Noh SH, Kim H (2016) Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favourable risk factor for lymph node metastasis in submucosa-invasive early gastic cancer. Gastric Cancer 19:1041\u20131051. https:\/\/doi.org\/10.1007\/s10120-015-0565-1","journal-title":"Gastric Cancer"},{"key":"2724_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s00535-019-01562-0","volume":"54","author":"H Osumi","year":"2019","unstructured":"Osumi H, Kawachi H, Yoshio T, Ida S, Yamamoto N, Horiuchi Y, Ishiyama A, Hirasawa T, Tsuchida T, Hiki N, Takeuchi K, Fujisaki J (2019) Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy. J Gastroenterol 54:774\u2013783. https:\/\/doi.org\/10.1007\/s00535-019-01562-0","journal-title":"J Gastroenterol"},{"key":"2724_CR21","unstructured":"Carneiro F, Fukayama M, Grabsch HI, Yasui W (2019) Gastric adenocarcinoma. In WHO Classification Editorial Board. Digestive system tumours (WHO calssification of tumours series, 5th ed.; vol.1), International Agency for Research on Cancer, Lyon, pp85\u201395"},{"key":"2724_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1097-0142(197607)38:1<232::AID-CNCR2820380135>3.0.CO;2-4","volume":"38","author":"H Watanabe","year":"1976","unstructured":"Watanabe H, Enjoji M, Imai T (1976) Gastric carcinoma with lymphoid stroma. Its morphological characteristics and prognostic correlations. Cancer 38:232\u2013243","journal-title":"Cancer"},{"key":"2724_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/ajcp\/aqx096","volume":"148","author":"RS Gonzalez","year":"2017","unstructured":"Gonzalez RS, Cates JMM, Revetta F, McMahon LA, Washington K (2017) Gastric carcinomas with lymphoid stroma: categorization and comparison with solid-type colonic carcinomas. Am J Clin Pathol 148:477\u2013484. https:\/\/doi.org\/10.1093\/ajcp\/aqx096","journal-title":"Am J Clin Pathol"},{"key":"2724_CR24","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/1097-0142(19940501)73:9<2239::AID-CNCR2820730902>3.0.CO;2-#","volume":"73","author":"S Nakamura","year":"1994","unstructured":"Nakamura S, Ueki T, Yao T, Ueyama T, Tsuneyoshi M (1994) Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer 73:2239\u20132249","journal-title":"Cancer"},{"key":"2724_CR25","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.cgh.2015.04.015","volume":"13","author":"H Lim","year":"2015","unstructured":"Lim H, Park YS, Lee JH, Son DH, Ahn JY, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY, Kim JH, Yook JH, Kim BS (2015) Features of gastric carcinoma with lymphoid stroma associated with Epstein-Barr virus. Clin Gastroenterol Hepatol 13:1738\u20131744.e2. https:\/\/doi.org\/10.1016\/j.cgh.2015.04.015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2724_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/PAS.0000000000001018","volume":"42","author":"E Hissong","year":"2018","unstructured":"Hissong E, Ramrattan G, Zhang P, Zhou XK, Young G, Klimstra DS, Shia J, Fernandes H, Yantiss RK (2018) Gastric carcinomas with lymphoid stroma: an evaluation of the histopathologic and molecular features. Am J Surg Pathol 42:453\u2013462. https:\/\/doi.org\/10.1097\/PAS.0000000000001018","journal-title":"Am J Surg Pathol"},{"key":"2724_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10120-018-0836-8","volume":"22","author":"I Gullo","year":"2019","unstructured":"Gullo I, Oliveira P, Athelogou M, Goncalves G, Pinto ML, Carvalho J, Valente A, Pinheiro H, Andrade S, Almeida GM, Huss R, Das K, Tan P, Machado JC, Oliveira C, Carneiro F (2019) New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression. Gastric Cancer 22:77\u201390. https:\/\/doi.org\/10.1007\/s10120-018-0836-8","journal-title":"Gastric Cancer"},{"issue":"7","key":"2724_CR28","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.3390\/ijms19072079","volume":"19","author":"Irene Gullo","year":"2018","unstructured":"Gullo I, Carvalho J, Martins D, Lemos D, Monteiro AR, Ferreira M, Das K, Tan P, Oliveira C, Carneiro F, Oliveira P (2018) The transcriptomic landscape of gastric cancer: insights into Epstein-Barr virus infected and microsatellite unstable tumors. Int J Mol Sci:19, E2079. https:\/\/doi.org\/10.3390\/ijms19072079","journal-title":"International Journal of Molecular Sciences"},{"key":"2724_CR29","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3892\/ijo.2015.2856","volume":"46","author":"A Shinozaki-Ushiku","year":"2015","unstructured":"Shinozaki-Ushiku A, Kunita A, Fukayama M (2015) Update on Epstein-Barr virus and gastric cancer (review). Int J Oncol 46:1421\u20131434. https:\/\/doi.org\/10.3892\/ijo.2015.2856","journal-title":"Int J Oncol"},{"key":"2724_CR30","first-page":"198","volume":"1","author":"H Uozaki","year":"2008","unstructured":"Uozaki H, Fukayama M (2008) Epstein-Barr virus associated gastric carcinoma-viral carcinogenesis through epigenetic mechanisms. Int J Clin Exp Pathol 1:198\u2013216","journal-title":"Int J Clin Exp Pathol"},{"key":"2724_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.semcancer.2014.01.002","volume":"26","author":"SC Kenney","year":"2014","unstructured":"Kenney SC, Mertz JE (2014) Regulation of the latent-lytic switch in Epstein-Barr virus. Semin Cancer Biol 26:60\u201368. https:\/\/doi.org\/10.1016\/j.semcancer.2014.01.002","journal-title":"Semin Cancer Biol"},{"key":"2724_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s101200050031","volume":"2","author":"Y Kaizaki","year":"1999","unstructured":"Kaizaki Y, Sakurai S, Chong JM, Fukayama M (1999) Atrophic gastritis, Epstein-Barr virus infection, and Epstein-Barr virus-associated gastric carcinoma. Gastric Cancer 2:101\u2013108","journal-title":"Gastric Cancer"},{"key":"2724_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1385\/IJGC:34:2-3:087","volume":"34","author":"A Hirano","year":"2003","unstructured":"Hirano A, Yanai H, Shimizu N, Okamoto T, Matsubara Y, Yamamoto K, Okita K (2003) Evaluation of Epstein-Barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay. Int J Gastrointest Cancer 34:87\u201394","journal-title":"Int J Gastrointest Cancer"},{"key":"2724_CR34","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1128\/JVI.72.5.4371-4378.1998","volume":"72","author":"S Imai","year":"1998","unstructured":"Imai S, Nishikawa J, Takada K (1998) Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72:4371\u20134378","journal-title":"J Virol"},{"issue":"1","key":"2724_CR35","doi-asserted-by":"publisher","first-page":"e0211358","DOI":"10.1371\/journal.pone.0211358","volume":"14","author":"Atsuhito Nakayama","year":"2019","unstructured":"Nakayama A, Abe H, Kunita A, Saito R, Kanda T, Yamashita H, Seto Y, Ishikawa S, Fukayama M Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma. PLoS One 14:e0211358. https:\/\/doi.org\/10.1371\/journal.pone.0211358","journal-title":"PLOS ONE"},{"key":"2724_CR36","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/cas.13954","volume":"110","author":"T Kanda","year":"2019","unstructured":"Kanda T, Yajima M, Ikuta K (2019) Epstein-Barr virus strain variation and cancer. Cancer Sci 110:1132\u20131139. https:\/\/doi.org\/10.1111\/cas.13954","journal-title":"Cancer Sci"},{"key":"2724_CR37","doi-asserted-by":"publisher","first-page":"E217","DOI":"10.3390\/cancers11020217","volume":"11","author":"AH Corvalan","year":"2019","unstructured":"Corvalan AH, Ruedlinger J, de Mayo T, Polakovicova I, Gonzalez-Hormazabal P, Aguayo F (2019) The phylogeographic diversity of EBV and admixed ancestry in the Americas: another model of disrupted human-pathogen co-evolution. Cancers (Basel) 11:E217. https:\/\/doi.org\/10.3390\/cancers11020217","journal-title":"Cancers (Basel)"},{"key":"2724_CR38","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1158\/0008-5472.CAN-11-3919","volume":"72","author":"A Kaneda","year":"2012","unstructured":"Kaneda A, Matsusaka K, Aburatani H, Fukayama M (2012) Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res 72:3445\u20133450. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3919","journal-title":"Cancer Res"},{"key":"2724_CR39","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.1158\/0008-5472.CAN-11-1349","volume":"71","author":"K Matsusaka","year":"2011","unstructured":"Matsusaka K, Kaneda A, Nagae G, Ushiku T, Kikuchi Y, Hino R, Uozaki H, Seto Y, Takada K, Aburatani H, Fukayama M (2011) Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res 71:7187\u20137197. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1349","journal-title":"Cancer Res"},{"key":"2724_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/path.4909","volume":"242","author":"K Matsusaka","year":"2017","unstructured":"Matsusaka K, Funata S, Fukuyo M, Seto Y, Aburatani H, Fukayama M, Kaneda A (2017) Epstein-Barr virus infection induces genome-wide de novo DNA methylation in non-neoplastic gastric epithelial cells. J Pathol 242:391\u2013399. https:\/\/doi.org\/10.1002\/path.4909","journal-title":"J Pathol"},{"key":"2724_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/B978-0-12-381280-3.00005-1","volume":"96","author":"JR Goldenring","year":"2010","unstructured":"Goldenring JR, Nam KT (2010) Oxyntic atrophy, metaplasia, and gastric cancer. Prog Mol Biol Transl Sci 96:117\u2013131. https:\/\/doi.org\/10.1016\/B978-0-12-381280-3.00005-1","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2724_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/path.4245","volume":"231","author":"RJ Port","year":"2013","unstructured":"Port RJ, Pinheiro-Maia S, Hu C, Arrand JR, Wei W, Young LS, Dawson CW (2013) Epstein-Barr virus induction of the hedgehog signaling pathway imposes a stem cell phenotype on human epithelial cells. J Pathol 231:367\u2013377. https:\/\/doi.org\/10.1002\/path.4245","journal-title":"J Pathol"},{"key":"2724_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1053\/j.gastro.2014.04.036","volume":"147","author":"T Shimizu","year":"2014","unstructured":"Shimizu T, Marusawa H, Matsumoto Y, Inuzuka T, Ikeda A, Fujii Y, Minamiguchi S, Miyamoto S, Kou T, Sakai Y, Crabtree JE, Chiba T (2014) Accumulation of somatic mutations in TP53 in gastric epithelium with helicobacter pylori infection. Gastroenterology 147:407\u2013417.e3. https:\/\/doi.org\/10.1053\/j.gastro.2014.04.036","journal-title":"Gastroenterology"},{"key":"2724_CR44","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000434683","volume":"82","author":"H Abe","year":"2015","unstructured":"Abe H, Kaneda A, Fukayama M (2015) Epstein-Barr virus associated gastric carcinoma: use of host cell machineries and somatic gene mutations. Pathobiology 82:212\u2013223. https:\/\/doi.org\/10.1159\/000434683","journal-title":"Pathobiology"},{"key":"2724_CR45","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1158\/0008-5472.CAN-08-3070","volume":"69","author":"R Hino","year":"2009","unstructured":"Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, Ishikawa S, Morikawa T, Nakaya T, Sakatani T, Takada K, Fukayama M (2009) Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 69:2766\u20132774. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3070","journal-title":"Cancer Res"},{"key":"2724_CR46","doi-asserted-by":"publisher","first-page":"81512","DOI":"10.18632\/oncotarget.13130","volume":"7","author":"H Namba-Fukuyo","year":"2016","unstructured":"Namba-Fukuyo H, Funata S, Matsusaka K, Fukuyo M, Rahmutulla B, Mano Y, Fukayama M, Aburatani H, Kaneda A (2016) TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection. Oncotarget 7:81512\u201381526. https:\/\/doi.org\/10.18632\/oncotarget.13130","journal-title":"Oncotarget"},{"key":"2724_CR47","doi-asserted-by":"publisher","first-page":"55265","DOI":"10.18632\/oncotarget.19423","volume":"8","author":"S Funata","year":"2017","unstructured":"Funata S, Matsusaka K, Yamanaka R, Yamamoto S, Okabe A, Fukuyo M, Aburatani H, Fukayama M, Kaneda A (2017) Histone modification alteration coordinated with acquisition of promoter DNA methylation during Epstein-Barr virus infection. Oncotarget 8:55265\u201355279. https:\/\/doi.org\/10.18632\/oncotarget.19423","journal-title":"Oncotarget"},{"key":"2724_CR48","doi-asserted-by":"publisher","first-page":"11442","DOI":"10.1128\/JVI.00972-14","volume":"88","author":"CE Birdwell","year":"2014","unstructured":"Birdwell CE, Queen KJ, Kilgore PC, Rollyson P, Trutschl M, Cvek U, Scott RS (2014) Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes. J Virol 88:11442\u201311458. https:\/\/doi.org\/10.1128\/JVI.00972-14","journal-title":"J Virol"},{"key":"2724_CR49","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.chom.2014.02.008","volume":"15","author":"M Hatakeyama","year":"2014","unstructured":"Hatakeyama M (2014) Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe 15:306\u2013316. https:\/\/doi.org\/10.1016\/j.chom.2014.02.008","journal-title":"Cell Host Microbe"},{"key":"2724_CR50","doi-asserted-by":"publisher","first-page":"16026","DOI":"10.1038\/nmicrobiol.2016.26","volume":"1","author":"P Saju","year":"2016","unstructured":"Saju P, Murata-Kamiya N, Hayashi T, Senda Y, Nagase L, Noda S, Matsusaka K, Funata S, Kunita A, Urabe M, Seto Y, Fukayama M, Kaneda A, Hatakeyama M (2016) Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus. Nat Microbiol 1:16026. https:\/\/doi.org\/10.1038\/nmicrobiol.2016.26","journal-title":"Nat Microbiol"},{"key":"2724_CR51","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/bjc.2015.175","volume":"112","author":"MG Cardenas-Mondragon","year":"2015","unstructured":"Cardenas-Mondragon MG, Torres J, Flores-Luna L, Camorlinga-Ponce M, Carreon-Talavera R, Gomez-Delgado A, Kasamatsu E, Fuentes-Panana EM (2015) Case control study of Epstein Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease. Br J Cancer 112:1866\u20131873. https:\/\/doi.org\/10.1038\/bjc.2015.175","journal-title":"Br J Cancer"},{"key":"2724_CR52","doi-asserted-by":"publisher","first-page":"E291","DOI":"10.3390\/v10060291","volume":"10","author":"YC Chen","year":"2018","unstructured":"Chen YC, Sheng J, Trang P, Liu F (2018) Potential application of the CRISPR\/Cas9 system against herpes virus infections. Viruses 10:E291. https:\/\/doi.org\/10.3390\/v10060291","journal-title":"Viruses"},{"key":"2724_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/01.pas.0000176428.06629.1e","volume":"30","author":"J van Beek","year":"2006","unstructured":"van Beek J, zur Hausen A, Snel SN, Berkhof J, Kranenbarg EK, van de Velde CJ, van den Brule AJ, Middeldorp JM, Meijer CJ, Bloemena E (2006) Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases. Am J Surg Pathol 30:59\u201365","journal-title":"Am J Surg Pathol"},{"key":"2724_CR54","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00428-005-0066-4","volume":"448","author":"AM Chiaravalli","year":"2006","unstructured":"Chiaravalli AM, Feltri M, Bertolini V, Bagnoli E, Furlan D, Cerutti R, Novario R, Capella C (2006) Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection. Virchows Arch 448:344\u2013353. https:\/\/doi.org\/10.1007\/s00428-005-0066-4","journal-title":"Virchows Arch"},{"key":"2724_CR55","doi-asserted-by":"publisher","first-page":"26356","DOI":"10.18632\/oncotarget.15465","volume":"8","author":"J Koh","year":"2017","unstructured":"Koh J, Ock CY, Kim JW, Nam SK, Kwak Y, Yun S, Ahn SH, Park DJ, Kim HH, Kim WH, Lee HS (2017) Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients. Oncotarget 8:26356\u201326367. https:\/\/doi.org\/10.18632\/oncotarget.15465","journal-title":"Oncotarget"},{"key":"2724_CR56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.humpath.2016.06.002","volume":"56","author":"T Ichimura","year":"2016","unstructured":"Ichimura T, Abe H, Morikawa T, Yamashita H, Ishikawa S, Ushiku T, Seto Y, Fukayama M (2016) Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus-associated gastric cancer: a clinicopathologic study with digital image analysis. Hum Pathol 56:74\u201380. https:\/\/doi.org\/10.1016\/j.humpath.2016.06.002","journal-title":"Hum Pathol"},{"key":"2724_CR57","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00428-016-1915-z","volume":"468","author":"H Abe","year":"2016","unstructured":"Abe H, Morikawa T, Saito R, Yamashita H, Seto Y, Fukayama M (2016) In Epstein-Barr virus-associated gastric carcinoma a high density of CD66b-positive tumor-associated neutrophils is associated with intestinal-type histology and low frequency of lymph node metastasis. Virchows Arch 468:539\u2013548. https:\/\/doi.org\/10.1007\/s00428-016-1915-z","journal-title":"Virchows Arch"},{"key":"2724_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003341","volume":"9","author":"MJ Strong","year":"2013","unstructured":"Strong MJ, Xu G, Coco J, Baribault C, Vinay DS, Lacey MR, Strong AL, Lehman TA, Seddon MB, Lin Z, Concha M, Baddoo M, Ferris M, Swan KF, Sullivan DE, Burow ME, Taylor CM, Flemington EK (2013) Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy. PLoS Pathog 9:e1003341. https:\/\/doi.org\/10.1371\/journal.ppat.1003341","journal-title":"PLoS Pathog"},{"key":"2724_CR59","doi-asserted-by":"publisher","unstructured":"Lu S, Wang LJ, Lombardo K, Kwak Y, Kim WH, Resnick MB (2019) Expression of indoleamine 2, 3-dioxygenase 1 (IDO1) and tryptophanyl-tRNA synthetase (WARS) in gastric cancer molecular subtypes. Appl Immunohistochem Mol Morphol. https:\/\/doi.org\/10.1097\/PAI.0000000000000761","DOI":"10.1097\/PAI.0000000000000761"},{"key":"2724_CR60","doi-asserted-by":"publisher","first-page":"18057","DOI":"10.1038\/srep18057","volume":"5","author":"NN Zhang","year":"2015","unstructured":"Zhang NN, Chen JN, Xiao L, Tang F, Zhang ZG, Zhang YW, Feng ZY, Jiang Y, Shao CK (2015) Accumulation mechanisms of CD4(+)CD25(+)FOXP3(+) regulatory T cells in EBV-associated gastric carcinoma. Sci Rep 5:18057. https:\/\/doi.org\/10.1038\/srep18057","journal-title":"Sci Rep"},{"key":"2724_CR61","doi-asserted-by":"publisher","first-page":"32925","DOI":"10.18632\/oncotarget.9076","volume":"7","author":"S Derks","year":"2016","unstructured":"Derks S, Liao X, Chiaravalli AM, Xu X, Camargo MC, Solcia E, Sessa F, Fleitas T, Freeman GJ, Rodig SJ, Rabkin CS, Bass AJ (2016) Abundant PD-L1 expression in Epstein-Barr virus-infected gastric cancers. Oncotarget 7:32925\u201332932. https:\/\/doi.org\/10.18632\/oncotarget.9076","journal-title":"Oncotarget"},{"key":"2724_CR62","doi-asserted-by":"publisher","first-page":"e000326","DOI":"10.1136\/esmoopen-2018-000326","volume":"3","author":"J Cho","year":"2018","unstructured":"Cho J, Chang YH, Heo YJ, Kim S, Kim NK, Park JO, Kang WK, Lee J, Kim KM (2018) Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability. ESMO Open 3:e000326. https:\/\/doi.org\/10.1136\/esmoopen-2018-000326","journal-title":"ESMO Open"},{"issue":"1","key":"2724_CR63","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10120-018-0843-9","volume":"22","author":"Akihito Kawazoe","year":"2018","unstructured":"Kawazoe A, Shitara K, Kuboki Y, Bando H, Kojima T, Yoshino T, Ohtsu A, Ochiai A, Togashi Y, Nishikawa H, Doi T, Kuwata T Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer. Gastric Cancer 22:69\u201376. https:\/\/doi.org\/10.1007\/s10120-018-0843-9","journal-title":"Gastric Cancer"},{"key":"2724_CR64","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/modpathol.2016.202","volume":"30","author":"R Saito","year":"2017","unstructured":"Saito R, Abe H, Kunita A, Yamashita H, Seto Y, Fukayama M (2017) Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1(+) immune cells in Epstein-Barr virus-associated gastric cancer: the prognostic implications. Mod Pathol 30:427\u2013443. https:\/\/doi.org\/10.1038\/modpathol.2016.202","journal-title":"Mod Pathol"},{"key":"2724_CR65","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ctrv.2018.04.004","volume":"66","author":"J Taieb","year":"2018","unstructured":"Taieb J, Moehler M, Boku N, Ajani JA, Yanez Ruiz E, Ryu MH, Guenther S, Chand V, Bang YJ (2018) Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: current status and future perspectives. Cancer Treat Rev 66:104\u2013113. https:\/\/doi.org\/10.1016\/j.ctrv.2018.04.004","journal-title":"Cancer Treat Rev"},{"key":"2724_CR66","doi-asserted-by":"publisher","first-page":"330","DOI":"10.5858\/arpa.2018-0043-OA","volume":"143","author":"K Kulangara","year":"2019","unstructured":"Kulangara K, Zhang N, Corigliano E, Guerrero L, Waldroup S, Jaiswal D, Ms MJ, Shah S, Hanks D, Wang J, Lunceford J, Savage MJ, Juco J, Emancipator K (2019) Clinical utility of the combined positive score for programmed death ligand-1 expression and the approval of pembrolizumab for treatment of gastric cancer. Arch Pathol Lab Med 143:330\u2013337. https:\/\/doi.org\/10.5858\/arpa.2018-0043-OA","journal-title":"Arch Pathol Lab Med"},{"key":"2724_CR67","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/jnci\/djx213","volume":"110","author":"A Panda","year":"2018","unstructured":"Panda A, Mehnert JM, Hirshfield KM, Riedlinger G, Damare S, Saunders T, Kane M, Sokol L, Stein MN, Poplin E, Rodriguez-Rodriguez L, Silk AW, Aisner J, Chan N, Malhotra J, Frankel M, Kaufman HL, Ali S, Ross JS, White EP, Bhanot G, Ganesan S (2018) Immune activation and benefit from avelumab in EBV-positive gastric cancer. J Natl Cancer Inst 110:316\u2013320. https:\/\/doi.org\/10.1093\/jnci\/djx213","journal-title":"J Natl Cancer Inst"},{"key":"2724_CR68","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00428-018-2332-2","volume":"472","author":"H Abe","year":"2018","unstructured":"Abe H, Saito R, Ichimura T, Iwasaki A, Yamazawa S, Shinozaki-Ushiku A, Morikawa T, Ushiku T, Yamashita H, Seto Y, Fukayama M (2018) CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8(+)\/Foxp3(+) T cells. Virchows Arch 472:643\u2013651. https:\/\/doi.org\/10.1007\/s00428-018-2332-2","journal-title":"Virchows Arch"},{"key":"2724_CR69","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1111\/cas.13663","volume":"109","author":"Y Murata","year":"2018","unstructured":"Murata Y, Saito Y, Kotani T, Matozaki T (2018) CD47-signal regulatory protein signaling system and its application to cancer immunotherapy. Cancer Sci 109:2349\u20132357. https:\/\/doi.org\/10.1111\/cas.13663","journal-title":"Cancer Sci"},{"key":"2724_CR70","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3389\/fmicb.2018.00636","volume":"9","author":"I Polakovicova","year":"2018","unstructured":"Polakovicova I, Jerez S, Wichmann IA, Sandoval-Borquez A, Carrasco-Veliz N, Corvalan AH (2018) Role of microRNAs and exosomes in Helicobacter pylori and Epstein-Barr virus associated gastric cancers. Front Microbiol 9:636. https:\/\/doi.org\/10.3389\/fmicb.2018.00636","journal-title":"Front Microbiol"},{"key":"2724_CR71","doi-asserted-by":"publisher","first-page":"11256","DOI":"10.1128\/JVI.01492-15","volume":"89","author":"AR Marquitz","year":"2015","unstructured":"Marquitz AR, Mathur A, Edwards RH, Raab-Traub N (2015) Host gene expression is regulated by two types of noncoding RNAs transcribed from the Epstein-Barr virus BamHI a rightward transcript region. J Virol 89:11256\u201311268. https:\/\/doi.org\/10.1128\/JVI.01492-15","journal-title":"J Virol"},{"key":"2724_CR72","doi-asserted-by":"publisher","first-page":"E8737","DOI":"10.1073\/pnas.1811728115","volume":"115","author":"T Toptan","year":"2018","unstructured":"Toptan T, Abere B, Nalesnik MA, Swerdlow SH, Ranganathan S, Lee N, Shair KH, Moore PS, Chang Y (2018) Circular DNA tumor viruses make circular RNAs. Proc Natl Acad Sci U S A 115:E8737\u2013E8745. https:\/\/doi.org\/10.1073\/pnas.1811728115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2724_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007206","volume":"14","author":"N Ungerleider","year":"2018","unstructured":"Ungerleider N, Concha M, Lin Z, Roberts C, Wang X, Cao S, Baddoo M, Moss WN, Yu Y, Seddon M, Lehman T, Tibbetts S, Renne R, Dong Y, Flemington EK (2018) The Epstein Barr virus circRNAome. PLoS Pathog 14:e1007206. https:\/\/doi.org\/10.1371\/journal.ppat.1007206","journal-title":"PLoS Pathog"},{"key":"2724_CR74","doi-asserted-by":"publisher","first-page":"28796","DOI":"10.18632\/oncotarget.15675","volume":"8","author":"K Shoda","year":"2017","unstructured":"Shoda K, Ichikawa D, Fujita Y, Masuda K, Hiramoto H, Hamada J, Arita T, Konishi H, Kosuga T, Komatsu S, Shiozaki A, Okamoto K, Imoto I, Otsuji E (2017) Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer. Oncotarget 8:28796\u201328804. https:\/\/doi.org\/10.18632\/oncotarget.15675","journal-title":"Oncotarget"},{"key":"2724_CR75","doi-asserted-by":"publisher","first-page":"E167","DOI":"10.3390\/cancers10060167","volume":"10","author":"J Nishikawa","year":"2018","unstructured":"Nishikawa J, Iizasa H, Yoshiyama H, Shimokuri K, Kobayashi Y, Sasaki S, Nakamura M, Yanai H, Sakai K, Suehiro Y, Yamasaki T, Sakaida I (2018) Clinical importance of Epstein-Barr virus-associated gastric cancer. Cancers (Basel) 10:E167. https:\/\/doi.org\/10.3390\/cancers10060167","journal-title":"Cancers (Basel)"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-019-02724-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T00:26:31Z","timestamp":1607732791000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-019-02724-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["2724"],"URL":"https:\/\/doi.org\/10.1007\/s00428-019-02724-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,13]]},"assertion":[{"value":"25 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Virchows Archiv conforms to the ICMJE recommendation for qualification of authorship. The ICMJE recommends that authorship be based on the following four criteria:","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical responsibilities of authors section"}}]}}